Evidence map›Paper›PMID 29581031›Full record

ArticleCellular signalling2018

IL-7-induced phosphorylation of the adaptor Crk-like and other targets.

Francesca B Aiello, Tad Guszczynski, Wenqing Li, Julie A Hixon, Qiong Jiang, Deborah L Hodge, Tania Massignan, Chiara Di Lisio, Anand Merchant, Antonio D Procopio and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Interleukin (IL)-7 Signaling in the Tumor Microenvironment.Advances in experimental medicine and biology · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Francesca B AielloCancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: fbaiello@unich.it.
Tad GuszczynskiMolecular Targets Laboratory, FCRDC, Bldg 560, Frederick, MD 21702, USA. Electronic address: Tad.guszczynski@mail.nih.gov.
Wenqing LiCancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: liwenq@mail.nih.gov.
Julie A HixonCancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: hixonj@mail.nih.gov.
Qiong JiangCancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: qiong.jiang@qiagen.com.
Deborah L HodgeLaboratory of Experimental Medicine, FCRDC, Bldg 560, Frederick, MD 21702, USA. Electronic address: hodged@mail.nih.gov.
Tania MassignanDulbecco Telethon Institute, IRCCS-Istituto di Ricerche Farmacologiche M. Negri, via La Masa 19, 20156 Milano, Italy.
Chiara Di LisioDepartment of Medicine and Aging Sciences, University of Chieti-Pescara, via dei Vestini, 66013 Chieti, Italy. Electronic address: chiara.dilisio@unich.it.
Anand MerchantCenter for Cancer Research, NIH, Bethesda, MD 20892, USA. Electronic address: anand.merchant@nih.gov.
Antonio D ProcopioDepartment of Clinical and Medical Sciences, Marche Polytechnic University, via Tronto 10, 60100 Ancona, Italy. Electronic address: a.d.procopio@univpm.it.
Valentina BonettoDulbecco Telethon Institute, IRCCS-Istituto di Ricerche Farmacologiche M. Negri, via La Masa 19, 20156 Milano, Italy. Electronic address: valentina.bonetto@marionegri.it.
Scott K DurumCancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: durum@mail.nih.gov.
Center for Cancer Research · USDulbecco Telethon Institute · ITMarche Polytechnic University · ITTarget (United States) · USUniversity of Chieti-Pescara · IT

Funding

Cytokines and T Cell DevelopmentZIABC009287 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURUM, SCOTT · 2009 to 2025
$15.5M
Chronic Inflammation and CarcinogenesisZIABC011150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURUM, SCOTT · 2009 to 2025
$8.5M
CYTOKINES AND T CELL DEVELOPMENTZ01BC009287 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURUM, SCOTT · 1996 to 2008
$1.9M
Intramural NIH HHS Z01 BC009287
6 · The paper itself

Abstract

IL-7 is required for T cell differentiation and mature T cell homeostasis and promotes pro-B cell proliferation and survival. Tyrosine phosphorylation plays a central role in IL-7 signaling. We identified by two-dimensional electrophoresis followed by anti-phosphotyrosine immunoblotting and mass spectrometry sixteen tyrosine phosphorylated proteins from the IL-7-dependent cell line D1. IL-7 stimulation induced the phosphorylation of the proteins STI1, ATIC and hnRNPH, involved in pathways related to survival, proliferation and gene expression, respectively, and increased the phosphorylation of CrkL, a member of a family of adaptors including the highly homologous Crk isoforms CrkII and CrkI, important in multiple signaling pathways. We observed an increased phosphorylation of CrkL in murine pro-B cells and in murine and human T cells. In addition, IL-7 increased the association of CrkL with the transcription factor Stat5, essential for IL-7 pro-survival activity. The selective tyrosine kinase inhibitor Imatinib. counteracted the IL-7 pro-survival effect in D1 cells and decreased CrkL phosphorylation. These data suggested that CrkL could play a pro-survival role in IL-7-mediated signaling. We observed that pro-B cells also expressed, in addition to CrkL, the Crk isoforms CrkII and CrkI and therefore utilized pro-B cells conditionally deficient in all three to evaluate the role of these proteins. The observation that the IL-7 pro-survival effect was reduced in Crk/CrkL conditionally-deficient pro-B cells further pointed to a pro-survival role of these adaptors. To further evaluate the role of these proteins, gene expression studies were performed in Crk/CrkL conditionally-deficient pro-B cells. IL-7 decreased the transcription of the receptor LAIR1, which inhibits B cell proliferation, in a Crk/CrkL-dependent manner, suggesting that the Crk family of proteins may promote pro-B cell proliferation. Our data contribute to the understanding of IL-7 signaling and suggest the involvement of Crk family proteins in pathways promoting survival and proliferation.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosisB-LymphocytesGene Expression RegulationHumansImatinib MesylateInterleukin-7MaleMiceMice, Inbred C57BLNuclear ProteinsPhosphorylationProtein IsoformsSignal TransductionSTAT5 Transcription FactorAdaptor Proteins, Signal TransducingCRKL proteinImatinib MesylateInterleukin-7Nuclear ProteinsProtein IsoformsSTAT5 Transcription FactorApoptosisCrk-likeImatinibInterleukin 7LAIR1Tyrosine phosphorylation

Identifiers

PMID29581031
PMCPMC7983156
OpenAlexW2789730294

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.